Cargando…

Corrigendum: Anti-embolism devices therapy to improve the ICU mortality rate of patients with acute myocardial infarction and type II diabetes mellitus

Detalles Bibliográficos
Autores principales: Huang, Xiaxuan, Zhang, Luming, Xu, Mengyuan, Yuan, Shiqi, Ye, Yan, Huang, Tao, Yin, Haiyan, Lyu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034531/
https://www.ncbi.nlm.nih.gov/pubmed/36970347
http://dx.doi.org/10.3389/fcvm.2023.1143652
_version_ 1784911241731375104
author Huang, Xiaxuan
Zhang, Luming
Xu, Mengyuan
Yuan, Shiqi
Ye, Yan
Huang, Tao
Yin, Haiyan
Lyu, Jun
author_facet Huang, Xiaxuan
Zhang, Luming
Xu, Mengyuan
Yuan, Shiqi
Ye, Yan
Huang, Tao
Yin, Haiyan
Lyu, Jun
author_sort Huang, Xiaxuan
collection PubMed
description
format Online
Article
Text
id pubmed-10034531
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100345312023-03-24 Corrigendum: Anti-embolism devices therapy to improve the ICU mortality rate of patients with acute myocardial infarction and type II diabetes mellitus Huang, Xiaxuan Zhang, Luming Xu, Mengyuan Yuan, Shiqi Ye, Yan Huang, Tao Yin, Haiyan Lyu, Jun Front Cardiovasc Med Cardiovascular Medicine Frontiers Media S.A. 2023-03-09 /pmc/articles/PMC10034531/ /pubmed/36970347 http://dx.doi.org/10.3389/fcvm.2023.1143652 Text en © 2023 Huang, Zhang, Xu, Yuan, Ye, Huang, Yin and Lyu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Huang, Xiaxuan
Zhang, Luming
Xu, Mengyuan
Yuan, Shiqi
Ye, Yan
Huang, Tao
Yin, Haiyan
Lyu, Jun
Corrigendum: Anti-embolism devices therapy to improve the ICU mortality rate of patients with acute myocardial infarction and type II diabetes mellitus
title Corrigendum: Anti-embolism devices therapy to improve the ICU mortality rate of patients with acute myocardial infarction and type II diabetes mellitus
title_full Corrigendum: Anti-embolism devices therapy to improve the ICU mortality rate of patients with acute myocardial infarction and type II diabetes mellitus
title_fullStr Corrigendum: Anti-embolism devices therapy to improve the ICU mortality rate of patients with acute myocardial infarction and type II diabetes mellitus
title_full_unstemmed Corrigendum: Anti-embolism devices therapy to improve the ICU mortality rate of patients with acute myocardial infarction and type II diabetes mellitus
title_short Corrigendum: Anti-embolism devices therapy to improve the ICU mortality rate of patients with acute myocardial infarction and type II diabetes mellitus
title_sort corrigendum: anti-embolism devices therapy to improve the icu mortality rate of patients with acute myocardial infarction and type ii diabetes mellitus
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034531/
https://www.ncbi.nlm.nih.gov/pubmed/36970347
http://dx.doi.org/10.3389/fcvm.2023.1143652
work_keys_str_mv AT huangxiaxuan corrigendumantiembolismdevicestherapytoimprovetheicumortalityrateofpatientswithacutemyocardialinfarctionandtypeiidiabetesmellitus
AT zhangluming corrigendumantiembolismdevicestherapytoimprovetheicumortalityrateofpatientswithacutemyocardialinfarctionandtypeiidiabetesmellitus
AT xumengyuan corrigendumantiembolismdevicestherapytoimprovetheicumortalityrateofpatientswithacutemyocardialinfarctionandtypeiidiabetesmellitus
AT yuanshiqi corrigendumantiembolismdevicestherapytoimprovetheicumortalityrateofpatientswithacutemyocardialinfarctionandtypeiidiabetesmellitus
AT yeyan corrigendumantiembolismdevicestherapytoimprovetheicumortalityrateofpatientswithacutemyocardialinfarctionandtypeiidiabetesmellitus
AT huangtao corrigendumantiembolismdevicestherapytoimprovetheicumortalityrateofpatientswithacutemyocardialinfarctionandtypeiidiabetesmellitus
AT yinhaiyan corrigendumantiembolismdevicestherapytoimprovetheicumortalityrateofpatientswithacutemyocardialinfarctionandtypeiidiabetesmellitus
AT lyujun corrigendumantiembolismdevicestherapytoimprovetheicumortalityrateofpatientswithacutemyocardialinfarctionandtypeiidiabetesmellitus